Werewolf Therapeutics Gestione
Gestione criteri di controllo 3/4
Werewolf Therapeutics Il CEO è Dan Hicklin, nominato in Oct2017, e ha un mandato di 7.08 anni. la retribuzione annua totale è $ 1.37M, composta da 42.7% di stipendio e 57.3% di bonus, comprese azioni e opzioni aziendali. possiede direttamente 1.45% delle azioni della società, per un valore di $ 1.23M. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 3.9 anni e 5.1 anni.
Informazioni chiave
Dan Hicklin
Amministratore delegato
US$1.4m
Compenso totale
| Percentuale dello stipendio del CEO | 42.7% |
| Mandato del CEO | 7.1yrs |
| Proprietà del CEO | 1.5% |
| Durata media del management | 3.9yrs |
| Durata media del Consiglio di amministrazione | 5.1yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Werewolf Therapeutics (NASDAQ:HOWL) Has Debt But No Earnings; Should You Worry?
Nov 14
Is Werewolf Therapeutics (NASDAQ:HOWL) Using Debt Sensibly?
Jul 31Werewolf Therapeutics: Continuing To Advance And Show More Promise In Phase 1
Jul 01Some Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Shareholders Look For Exit As Shares Take 34% Pounding
Jun 04Werewolf Therapeutics: In The Hunt For Success In The Cytokine Space
Apr 04Werewolf Therapeutics, Inc.'s (NASDAQ:HOWL) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Feb 07Is Werewolf Therapeutics (NASDAQ:HOWL) A Risky Investment?
Jan 19There's No Escaping Werewolf Therapeutics, Inc.'s (NASDAQ:HOWL) Muted Revenues Despite A 28% Share Price Rise
Dec 09Analysts Just Shipped A Captivating Upgrade To Their Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Estimates
Sep 30Werewolf Therapeutics, Inc. (NASDAQ:HOWL) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 13We're Hopeful That Werewolf Therapeutics (NASDAQ:HOWL) Will Use Its Cash Wisely
May 06Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans
Jan 27We're Not Very Worried About Werewolf Therapeutics' (NASDAQ:HOWL) Cash Burn Rate
Oct 24We're Hopeful That Werewolf Therapeutics (NASDAQ:HOWL) Will Use Its Cash Wisely
Jul 08Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans
Mar 24Werewolf Therapeutics (NASDAQ:HOWL) Is In A Good Position To Deliver On Growth Plans
Dec 09Analisi delle retribuzioni degli amministratori delegati
| Data | Compenso totale | Stipendio | Guadagni aziendali |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$62m |
| Jun 30 2024 | n/a | n/a | -US$54m |
| Mar 31 2024 | n/a | n/a | -US$42m |
| Dec 31 2023 | US$1m | US$583k | -US$37m |
| Sep 30 2023 | n/a | n/a | -US$37m |
| Jun 30 2023 | n/a | n/a | -US$41m |
| Mar 31 2023 | n/a | n/a | -US$50m |
| Dec 31 2022 | US$2m | US$530k | -US$54m |
| Sep 30 2022 | n/a | n/a | -US$60m |
| Jun 30 2022 | n/a | n/a | -US$62m |
| Mar 31 2022 | n/a | n/a | -US$115m |
| Dec 31 2021 | US$2m | US$498k | -US$202m |
| Sep 30 2021 | n/a | n/a | -US$205m |
| Jun 30 2021 | n/a | n/a | -US$197m |
| Mar 31 2021 | n/a | n/a | -US$127m |
| Dec 31 2020 | US$3m | US$425k | -US$28m |
Compensazione vs Mercato: La retribuzione totale di Dan ($USD 1.37M ) è superiore alla media delle aziende di dimensioni simili nel mercato US ($USD 649.07K ).
Compensazione vs guadagni: La retribuzione di Dan è stata coerente con le performance aziendali dell'ultimo anno.
AMMINISTRATORE DELEGATO
Dan Hicklin (60 yo)
7.1yrs
Mandato
US$1,366,904
Compensazione
Dr. Daniel J. Hicklin, Ph D., also known as Dan, Founded Werewolf Therapeutics, Inc. in October 2017 and has been its President and Chief Executive Officer since August 2019. He serves on its Board of Dire...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Founder | 7.1yrs | US$1.37m | 1.45% $ 1.2m | |
| CFO, Treasurer & Assistant Secretary | 3.8yrs | US$815.59k | 0% $ 0 | |
| Chief Medical Officer | 4yrs | US$855.77k | 0% $ 0 | |
| Senior Vice President of Research | less than a year | Nessun dato | Nessun dato | |
| Chief Technology Officer | 3.4yrs | US$3.86m | Nessun dato | |
| Chief Business Officer | 4.3yrs | Nessun dato | Nessun dato |
3.9yrs
Durata media
64yo
Età media
Gestione esperta: Il team dirigenziale di HOWL è considerato esperto (durata media dell'incarico 3.9 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Founder | 7.1yrs | US$1.37m | 1.45% $ 1.2m | |
| Independent Chairman of the Board | 7.1yrs | US$104.03k | 0% $ 0 | |
| Independent Director | 3.5yrs | US$78.66k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Independent Director | 5yrs | US$62.32k | 0.035% $ 29.5k | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board & Director | 6.3yrs | Nessun dato | 0.032% $ 27.4k | |
| Independent Director | 5.3yrs | US$78.53k | 4.59% $ 3.9m | |
| Independent Director | 3.1yrs | US$65.36k | 0% $ 0 | |
| Independent Director | 3.9yrs | US$72.53k | 0% $ 0 | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato |
5.1yrs
Durata media
61yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di HOWL sono considerati esperti (durata media dell'incarico 5.1 anni).